Pentagon Mandates Annual Testosterone Screening for Service Members Over 30

The Pentagon has announced a new requirement for all active-duty and reserve service members aged 30 and older to undergo annual screening for testosterone deficiency. This decision follows advocacy from veterans, including Chad Robichaux, who highlighted the need for better detection of hormonal imbalances that can affect mental and physical health. Secretary of War Pete Hegseth stated that the initiative aims to establish a baseline across the military and allow for targeted therapy when appropriate. The mandate could potentially affect over 451,000 active-duty service members, although the exact number of those subject to screening has not been disclosed. The policy reflects ongoing discussions in the medical community regarding the treatment of symptoms like fatigue and depression, which may be linked to hormonal disorders. The directive does not yet clarify how testosterone deficiency will be defined for women, nor does it provide details on the prevalence of such conditions among service members compared to civilians. The Endocrine Society has expressed caution regarding population-wide screening, emphasizing the need for thorough evaluation before treatment.